Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 2 |
2004 | 2 |
2023 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy.
Int J Mol Med. 2004 May;13(5):705-10.
Int J Mol Med. 2004.
PMID: 15067374
Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
Määttä AM, Tenhunen A, Pasanen T, Meriläinen O, Pellinen R, Mäkinen K, Alhava E, Wahlfors J.
Määttä AM, et al. Among authors: pasanen t.
Int J Oncol. 2004 Apr;24(4):943-9.
Int J Oncol. 2004.
PMID: 15010834
Item in Clipboard
Polyamine biosynthesis inhibition enhances HSV-1 thymidine kinase/ganciclovir-mediated cytotoxicity in tumor cells.
Pasanen T, Karppinen A, Alhonen L, Jänne J, Wahlfors J.
Pasanen T, et al.
Int J Cancer. 2003 Apr 10;104(3):380-8. doi: 10.1002/ijc.10942.
Int J Cancer. 2003.
PMID: 12569563
Free article.
Item in Clipboard
TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
Pasanen T, Hakkarainen T, Timonen P, Parkkinen J, Tenhunen A, Loimas S, Wahlfors J.
Pasanen T, et al.
Int J Mol Med. 2003 Oct;12(4):525-31.
Int J Mol Med. 2003.
PMID: 12964030
Item in Clipboard
Cite
Cite